Pharmaceutical Companies Pay Over $400 Million to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drugs

Three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, have agreed to pay a total of $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. These conspiracies allegedly resulted in higher drug prices for federal health care programs and beneficiaries according to the Justice Department.

Bonus Reports:

Justice Department Requires Divestiture for General Shale to Proceed with Acquisition of Meridian Brick

Chief Engineer and Greek Ship Owner and Operator Charged with Concealing Deliberate Pollution and Failing to Report a Hazardous Condition

Justice Department Settles Sexual Harassment Lawsuit Against Arkansas Housing Authority

Source: The U.S. Department of Justice (Office of Public Affairs)